Innophos (IPHS) Receiving Somewhat Favorable Press Coverage, Accern Reports

Headlines about Innophos (NASDAQ:IPHS) have been trending somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innophos earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave news articles about the specialty chemicals company an impact score of 48.0631772545735 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Several equities analysts recently commented on the company. BidaskClub cut Innophos from a “buy” rating to a “hold” rating in a research report on Saturday, January 6th. TheStreet cut Innophos from a “b-” rating to a “c” rating in a research report on Wednesday, February 21st. Finally, Zacks Investment Research cut Innophos from a “buy” rating to a “hold” rating in a report on Thursday, December 14th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and one has assigned a buy rating to the stock. Innophos currently has a consensus rating of “Hold” and an average target price of $50.00.

Innophos (NASDAQ IPHS) opened at $43.72 on Tuesday. Innophos has a fifty-two week low of $40.45 and a fifty-two week high of $54.65. The company has a quick ratio of 1.36, a current ratio of 2.64 and a debt-to-equity ratio of 0.93. The stock has a market capitalization of $848.62, a PE ratio of 39.04 and a beta of 0.83.

Innophos (NASDAQ:IPHS) last posted its quarterly earnings data on Wednesday, February 21st. The specialty chemicals company reported $0.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.04). Innophos had a return on equity of 14.02% and a net margin of 3.11%. The firm had revenue of $193.10 million during the quarter, compared to analysts’ expectations of $194.25 million. During the same quarter in the previous year, the company posted $0.52 earnings per share. Innophos’s revenue for the quarter was up 15.1% compared to the same quarter last year. research analysts anticipate that Innophos will post 2.7 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 16th. Stockholders of record on Friday, March 9th will be issued a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.39%. The ex-dividend date of this dividend is Thursday, March 8th. Innophos’s payout ratio is currently 171.43%.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Markets Daily and is the property of of Markets Daily. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.themarketsdaily.com/2018/03/13/innophos-iphs-receiving-somewhat-favorable-press-coverage-accern-reports.html.

Innophos Company Profile

Innophos Holdings, Inc is an international producer of specialty ingredient solutions that deliver for the food, health, nutrition and industrial markets. The Company’s segments include Food, Health and Nutrition, Industrial Specialties and Other. It offers a range of product categories, such as asphalt, catalyst, fertilizer salts, liquid phosphate, phosphate salt, phosphoric acid, polyphosphoric acid, sodium bicarbonate, and food blends.

Insider Buying and Selling by Quarter for Innophos (NASDAQ:IPHS)

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply